• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
News > U.S.

US Reports Over 470 Cases of Coronavirus Variants

  • Workers in action inside the Ellume laboratory that manufactures COVID-19 home test for the U.S. Department of Defense, Brisbane, Australia, Feb. 2, 2021.

    Workers in action inside the Ellume laboratory that manufactures COVID-19 home test for the U.S. Department of Defense, Brisbane, Australia, Feb. 2, 2021. | Photo: EFE

Published 2 February 2021
Opinion

The Biden administration announced a US$230 million deal to ramp up production of the country's first over-the-counter, at-home COVID-19 test.

The U.S. Centers for Disease Control and Prevention (CDC) reported that over 470 infection cases of coronavirus variants have been reported in at least 32 U.S. states.

RELATED:

Fears of US Interference in Ecuadorean Elections

The vast majority of these cases, 467, are caused by the variant known as B.1.1.7, which was originally detected in Britain. There are three cases of a new strain initially discovered in South Africa, called B.1.351, and one case of the P.1 strain first discovered in Brazil.

These cases identified are based on a sampling of SARS-CoV-2-positive specimens, and do not represent the total number of coronavirus variant cases that may be circulating in the U.S. The number may not match numbers reported by states, territories, tribes, and local officials, the CDC cautioned.

January has been by far the deadliest month of the pandemic in the country, with over 95,000 COVID-19 deaths, surpassing December's total of over 77,000 deaths, according to Johns Hopkins University.

President Joe Biden's administration announced on Monday a 230-million-U.S.-dollar deal to ramp up production of the country's first over-the-counter, at-home COVID-19 test.

"These are over-the-counter, self-performed test kits that can detect COVID with roughly 95 percent accuracy within 15 minutes," Andy Slavitt, White House senior adviser for COVID-19 response, told reporters.

In December, the U.S. Food and Drug Administration authorized Australian company Ellume's COVID-19 test for emergency use. This antigen test, sold over-the-counter, can be done at home using a nasal swab, dropper, and processing fluid.

The United States has recorded over 26.21 million COVID-19 cases with over 441,700 related deaths as of Monday afternoon.

Comment
0
Comments
Post with no comments.